US Physical Therapy (USPH) Tops Q4 EPS by 8c, FY EPS Guidance About In-Line
US Physical Therapy (NYSE: USPH) reported Q4 EPS of $0.71, $0.08 better than the analyst estimate of $0.63. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $117.03 million.
GUIDANCE:
US Physical Therapy sees FY2019 EPS of $2.76-$2.85, versus the consensus of $2.80.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
